US3274063A - Cosmetic cream - Google Patents
Cosmetic cream Download PDFInfo
- Publication number
- US3274063A US3274063A US118495A US11849561A US3274063A US 3274063 A US3274063 A US 3274063A US 118495 A US118495 A US 118495A US 11849561 A US11849561 A US 11849561A US 3274063 A US3274063 A US 3274063A
- Authority
- US
- United States
- Prior art keywords
- cosmetic
- magnesium
- cream
- magnesium aspartate
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Definitions
- Cosmetic creams usually comprise emulsion systems of the oil-in-water, or water-in-oil type, or combinations thereof. They are used, for instance, as cold creams or vanishing creams, for smoothing and softening the skin.
- magnesium aspartate also known as magnesium asparaginate
- the properties of the cream are considerably improved as far as the effect on the skin is concerned.
- the skin becomes much softer and smoother than when ordinary cosmetic creams are used.
- a cosmetic cream in accordance with the invention includes about 0.05 to 10 percent by weight of magnesium aspartate.
- magnesium in form of said salt is only slightly dissociated in the blood and body liquids, passes easily through the cell walls, and then readily exerts its particular effects inside the cell.
- the effect of intracellular magnesium consists in an activation of the metabolism ferments of thee esterase type. Such activation improves the growth of the basal layer of the epidermis and produces an increased bonding of intracellular water, increasing the size and tension of the cells.
- the magnesium salt of glutamic acid which, like aspartic acid, is a dicarboxylic amino acid, does not show the beneficial effect of the magnesium aspartate.
- the classic model for epithelial tissue is the monkey kidney cell monolayer in cultivation flasks.
- sterile rhesus kidney cortex tissue treated by Rapaport-trypsination, or hela cells were suspended 1:400 in a culture medium.
- A's culture medium, a lactalbumin hydrolysate 0.5% in Hanks salt solution, 10% calf serum added was used.
- test flasks were filled with 90 ml. of the cell containing medium; after 7 days, the culture was treated with 0.2% trypsin solution and then centrifuged. The obtained cell quantity was measure-d in milliliters.
- the following table gives the results:
- mag* nesium aspartate is its low cost and lack of any irritating effects, even when used in comparatively large proportions.
- the preferred bases are beeswax; water-soluble fats containing a high proportion of synthetic partial glycerides of saturated fatty hydroxyl groups containing acids having 12 to 18 C atoms, preferably in mixture with 50% of triglycerides; the bases disclosed in German Patent No. 1,090,824; the products of US. Patent No. 2,684,970, mixed with glycerol or cetyl alcohol as emollients.
- the magnesium aspartate is soluble in most cream bases and may be directly incorporated therein. We prefer to prepare a concentrated solution of the magnesium aspartate and admix the solution to the cream base.
- Example 1 is particularly useful for restoring the smooth texture of skin which has been affected by an excessive use of mascara.
- the magnesium aspartate may also be used in the form of jellies, whereby any conventional gel such as gelatin, agar-agar, alginates, carrageen, pectin, methyl cellulose may be used.
- Example 2 Skin lotion Parts Magnesium aspartate 1 Peanut oil, ad 100 Insteadof the peanut oil, we may use other vegetable oils such as olive oil, arachis oil, castor oil, animal oils .such as neats-foot oil, spermaceti; or also mineral oils such as paraffin oil.
- vegetable oils such as olive oil, arachis oil, castor oil, animal oils .such as neats-foot oil, spermaceti; or also mineral oils such as paraffin oil.
- a cosmetic preparation containing a cosmetic fatty cream base and incorporated therein about 0.05 to 10 percent by weight of magnesium aspartate, said magnesium aspartate enhancing the skin-softening effect of said cosmetic fatty base.
- a cosmetic cream comprising an emulsion of oil in water, and from about 0.05% to 10% by weight of magnesium aspartate, said magnesium aspartate enhancing the skin-softening efiect of the cosmetic cream.
- a cosmetic preparation comprising an oil and about 0.05 to 10 percent by weight of magnesium aspartate dis- References Cited by the Examiner UNITED STATES PATENTS 3,009,859 11/1961 Laborit et a1. 167-68 3,016,334 1/1962 Lewis 16758 3,061,512 10/1962 Anderson et al 1679l S. ROSEN, Primary Examiner.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEN15392A DE1099128B (de) | 1958-07-24 | 1958-07-24 | Mittel zur Pflege sowie zur Foerderung des Wachstums der Haut, der Haare und der Naegel |
DEN15614A DE1131847B (de) | 1958-07-24 | 1958-09-22 | Mittel zur Pflege sowie zur Foerderung des Wachstums der Haut, der Haare und der Naegel |
US82872159A | 1959-07-22 | 1959-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3274063A true US3274063A (en) | 1966-09-20 |
Family
ID=38544056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US118495A Expired - Lifetime US3274063A (en) | 1958-07-24 | 1961-06-21 | Cosmetic cream |
Country Status (6)
Country | Link |
---|---|
US (1) | US3274063A (es) |
BE (1) | BE580575A (es) |
CH (1) | CH379060A (es) |
DE (2) | DE1099128B (es) |
GB (1) | GB937362A (es) |
NL (2) | NL241476A (es) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932622A (en) * | 1974-01-11 | 1976-01-13 | General Foods Corporation | Skin moisturizer |
US20030013693A1 (en) * | 1998-02-11 | 2003-01-16 | Rtp Pharma Inc. | Method and composition for treatment of inflammatory conditions |
US20030059484A1 (en) * | 1996-11-07 | 2003-03-27 | Lvmh Recherche | Cosmetic treatment method for fighting against skin ageing effects |
US6576264B1 (en) | 1995-10-17 | 2003-06-10 | Skyepharma Canada Inc. | Insoluble drug delivery |
US6634576B2 (en) | 2000-08-31 | 2003-10-21 | Rtp Pharma Inc. | Milled particles |
US6682761B2 (en) | 2000-04-20 | 2004-01-27 | Rtp Pharma, Inc. | Water-insoluble drug particle process |
US20040086571A1 (en) * | 2001-02-22 | 2004-05-06 | Skyepharma Canada Inc. | Fibrate-statin combinations with reduced fed-fasted effects |
US7041705B2 (en) | 1998-08-19 | 2006-05-09 | Jagotec Ag | Injectable aqueous dispersions of propofol |
US7255877B2 (en) | 1996-08-22 | 2007-08-14 | Jagotec Ag | Fenofibrate microparticles |
FR2932086A1 (fr) * | 2008-06-06 | 2009-12-11 | Lvmh Rech | Methode de soin cosmetique anti-age par stimulation de l'expression de la survivine |
US7939106B2 (en) | 1998-11-20 | 2011-05-10 | Jagotec Ag | Process for preparing a rapidly dispersing solid drug dosage form |
US8206746B2 (en) | 1996-08-22 | 2012-06-26 | Jagotec Ag | Microparticles of water-insoluble substances |
US8415329B1 (en) | 1998-05-29 | 2013-04-09 | Jagotec Ag | Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations |
US8586094B2 (en) | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
US20170056279A1 (en) * | 2015-08-25 | 2017-03-02 | Francis Jack Wright | Nerve suppression device |
US10751267B2 (en) | 2016-12-21 | 2020-08-25 | Conopco, Inc. | Personal care compositions comprising poorly soluble compounds |
US11077039B2 (en) | 2016-12-21 | 2021-08-03 | Conopco, Inc. | Topical skin lightening additive and composition with amino acids and nicotinamide compounds |
US11260005B2 (en) | 2016-12-21 | 2022-03-01 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
US11337908B2 (en) | 2016-12-21 | 2022-05-24 | Conopco, Inc. | Personal care compositions with cystine |
US20220313586A1 (en) * | 2021-03-31 | 2022-10-06 | L'oreal | Cosmetic composition with glaucine, retinol and peptides to combat skin aging |
US11540984B2 (en) | 2018-05-23 | 2023-01-03 | Conopco, Inc. | Nanoemulsions and a method for making the same |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4154823A (en) * | 1976-06-10 | 1979-05-15 | Schutt Steven R | Skin treatment compositions and methods of using same |
IT8167097A0 (it) * | 1981-01-26 | 1981-01-26 | Unilever Nv | Composizione cosmetica per il trattamento della pelle o dei capelli |
US4837012A (en) * | 1987-06-19 | 1989-06-06 | S. C. Johnson & Son, Inc. | Hair reviver composition containing film-forming amino acids |
GB9222772D0 (en) * | 1992-10-30 | 1992-12-09 | Unilever Plc | Cosmetic composition |
US5397574A (en) * | 1993-10-04 | 1995-03-14 | Andrx Pharmaceuticals, Inc. | Controlled release potassium dosage form |
US5962523A (en) * | 1996-10-25 | 1999-10-05 | Discovery Laboratories, Inc. | Methods of using butyric acid derivatives to protect against hair loss |
GB9622659D0 (en) * | 1996-10-31 | 1997-01-08 | Unilever Plc | Hair treatment composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3009859A (en) * | 1958-07-22 | 1961-11-21 | Laborit Henri | Potassium aspartate and magnesium aspartate fatigue-recovery promoting process and compositions |
US3016334A (en) * | 1958-11-24 | 1962-01-09 | Thomas J Lewis | Skin cream containing low gel strength, low viscosity gelatin |
US3061512A (en) * | 1959-06-25 | 1962-10-30 | Borden Co | Dermatological preparation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2032042A (en) * | 1934-06-30 | 1936-02-25 | Northam Warren Corp | Fingernail polish remover |
US2719811A (en) * | 1945-10-01 | 1955-10-04 | Inst Divi Thomae Foundation | Means for controlling the respiration of animal cells |
-
0
- NL NL120093D patent/NL120093C/xx active
- NL NL241476D patent/NL241476A/xx unknown
-
1958
- 1958-07-24 DE DEN15392A patent/DE1099128B/de active Pending
- 1958-09-22 DE DEN15614A patent/DE1131847B/de active Pending
-
1959
- 1959-07-10 BE BE580575A patent/BE580575A/fr unknown
- 1959-11-17 CH CH8069759A patent/CH379060A/de unknown
- 1959-12-23 GB GB43782/59A patent/GB937362A/en not_active Expired
-
1961
- 1961-06-21 US US118495A patent/US3274063A/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3009859A (en) * | 1958-07-22 | 1961-11-21 | Laborit Henri | Potassium aspartate and magnesium aspartate fatigue-recovery promoting process and compositions |
US3016334A (en) * | 1958-11-24 | 1962-01-09 | Thomas J Lewis | Skin cream containing low gel strength, low viscosity gelatin |
US3061512A (en) * | 1959-06-25 | 1962-10-30 | Borden Co | Dermatological preparation |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932622A (en) * | 1974-01-11 | 1976-01-13 | General Foods Corporation | Skin moisturizer |
US20040018229A1 (en) * | 1995-10-17 | 2004-01-29 | Henriksen Inge B. | Insoluble drug delivery |
US6576264B1 (en) | 1995-10-17 | 2003-06-10 | Skyepharma Canada Inc. | Insoluble drug delivery |
US6974593B2 (en) | 1995-10-17 | 2005-12-13 | Jagotec Ag | Insoluble drug delivery |
US8206746B2 (en) | 1996-08-22 | 2012-06-26 | Jagotec Ag | Microparticles of water-insoluble substances |
US7255877B2 (en) | 1996-08-22 | 2007-08-14 | Jagotec Ag | Fenofibrate microparticles |
US20030059484A1 (en) * | 1996-11-07 | 2003-03-27 | Lvmh Recherche | Cosmetic treatment method for fighting against skin ageing effects |
US7678380B2 (en) * | 1996-11-07 | 2010-03-16 | Lvmh Recherche | Cosmetic treatment method for fighting against skin ageing effects |
US20090297639A1 (en) * | 1996-11-07 | 2009-12-03 | Lvmh Recherche | Cosmetic treatement method for fighting against skin ageing effects |
US20030013693A1 (en) * | 1998-02-11 | 2003-01-16 | Rtp Pharma Inc. | Method and composition for treatment of inflammatory conditions |
US8415329B1 (en) | 1998-05-29 | 2013-04-09 | Jagotec Ag | Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations |
US7041705B2 (en) | 1998-08-19 | 2006-05-09 | Jagotec Ag | Injectable aqueous dispersions of propofol |
US7097849B2 (en) | 1998-08-19 | 2006-08-29 | Jagotec Ag | Injectable aqueous dispersions of propofol |
US7939106B2 (en) | 1998-11-20 | 2011-05-10 | Jagotec Ag | Process for preparing a rapidly dispersing solid drug dosage form |
US7939105B2 (en) | 1998-11-20 | 2011-05-10 | Jagotec Ag | Process for preparing a rapidly dispersing solid drug dosage form |
US6682761B2 (en) | 2000-04-20 | 2004-01-27 | Rtp Pharma, Inc. | Water-insoluble drug particle process |
US6634576B2 (en) | 2000-08-31 | 2003-10-21 | Rtp Pharma Inc. | Milled particles |
US8586094B2 (en) | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
US8703202B2 (en) | 2000-09-20 | 2014-04-22 | Jagotec Ag | Coated tablets |
US20040086571A1 (en) * | 2001-02-22 | 2004-05-06 | Skyepharma Canada Inc. | Fibrate-statin combinations with reduced fed-fasted effects |
US20100040706A1 (en) * | 2008-06-06 | 2010-02-18 | Lvmh Recherche | Method of anti-ageing cosmetic care by stimulation of survivin expression |
FR2932086A1 (fr) * | 2008-06-06 | 2009-12-11 | Lvmh Rech | Methode de soin cosmetique anti-age par stimulation de l'expression de la survivine |
US20170056279A1 (en) * | 2015-08-25 | 2017-03-02 | Francis Jack Wright | Nerve suppression device |
US10751267B2 (en) | 2016-12-21 | 2020-08-25 | Conopco, Inc. | Personal care compositions comprising poorly soluble compounds |
US10980718B2 (en) | 2016-12-21 | 2021-04-20 | Conopco, Inc. | Personal care compositions comprising poorly soluble compounds |
US11077039B2 (en) | 2016-12-21 | 2021-08-03 | Conopco, Inc. | Topical skin lightening additive and composition with amino acids and nicotinamide compounds |
US11260005B2 (en) | 2016-12-21 | 2022-03-01 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
US11337908B2 (en) | 2016-12-21 | 2022-05-24 | Conopco, Inc. | Personal care compositions with cystine |
US11596586B2 (en) | 2016-12-21 | 2023-03-07 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
US11666519B2 (en) | 2016-12-21 | 2023-06-06 | Conopco, Inc. | Personal care compositions with cystine |
US11759412B2 (en) | 2016-12-21 | 2023-09-19 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
US11540984B2 (en) | 2018-05-23 | 2023-01-03 | Conopco, Inc. | Nanoemulsions and a method for making the same |
US20220313586A1 (en) * | 2021-03-31 | 2022-10-06 | L'oreal | Cosmetic composition with glaucine, retinol and peptides to combat skin aging |
Also Published As
Publication number | Publication date |
---|---|
NL120093C (es) | |
CH379060A (de) | 1964-06-30 |
BE580575A (fr) | 1960-01-11 |
NL241476A (es) | |
DE1131847B (de) | 1962-06-20 |
GB937362A (en) | 1963-09-18 |
DE1099128B (de) | 1961-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3274063A (en) | Cosmetic cream | |
CN1933805B (zh) | 减少因衰老而出现的皱纹的化妆品或皮肤用药 | |
JPS63192703A (ja) | 皮膚外用剤 | |
JPH07196469A (ja) | 混成皮膚の手入れのための化粧品組成物 | |
US3574854A (en) | Method for soothing the skin with a cream containing sodium chloride | |
EP0084341B1 (en) | Emulsion-type composition for external use | |
WO2000004047A1 (fr) | Compositions cosmetiques amincissantes | |
JP3607062B2 (ja) | 脂肪蓄積抑制剤及びそれを含有する皮膚外用剤 | |
JPS5826726B2 (ja) | ケシヨウリヨウ | |
US2294229A (en) | Cosmetic preparations | |
US4107333A (en) | Skin care with a cosmetic composition containing oleyl acetate | |
Walker et al. | Influence of alcohol on collagen synthesis in vitro | |
JPS62120308A (ja) | 化粧料 | |
JPH0521085B2 (es) | ||
JPS61204109A (ja) | 乳化型の外用組成物 | |
US2520980A (en) | Cosmetic creams | |
JP3262780B2 (ja) | フィトスフィンゴシン水溶液、その製造方法及び使用方法 | |
JPS6127908A (ja) | 肌荒れ防止剤 | |
SU992058A1 (ru) | Средство дл искусственного загара | |
US1073787A (en) | Cosmetic cream. | |
JPH04108721A (ja) | 細胞賦活剤組成物 | |
JPH10182409A (ja) | 化粧料 | |
CN108379212A (zh) | 一种具有抗衰老功效的驼乳滋润面霜及其制备方法 | |
TWI780699B (zh) | 乳鐵蛋白、其衍生胜肽及其抑制及/或減緩油脂生成的用途 | |
JPS6256132B2 (es) |